Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason C Yam

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
The British Journal of Ophthalmology|February 6, 2024
Pan-Indian multicentre retrospective study of 0.01% atropine for myopia controlJason C Yam, Yuzhou Zhang
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|September 4, 2019
Low-Concentration Atropine Eye Drops for Myopia ProgressionFen Fen Li, Jason C Yam
BMC Ophthalmology|June 6, 2022
A retrospective study of strabismus surgery in a tertiary eye hospital in the Chaoshan area in China from 2014 to 2020Yu Bi, Jason C Yam, Shibin Lin
American Journal of Ophthalmology|June 6, 2022
Reply to Comment on: The Association of Choroidal Thickening by Atropine with Treatment Effects for Myopia: Two-Year Clinical Trial of the LAMP StudyXiu Juan Zhang, Yuzhou Zhang, Jason C Yam
JAMA|June 6, 2023
Low-Concentration Atropine Eyedrops for Myopia in Children-ReplyXiu Juan Zhang, Yuzhou Zhang, Jason C Yam
International Journal of Molecular Sciences|October 13, 2021
Poly ADP Ribose Polymerase Inhibitor Olaparib Targeting Microhomology End Joining in Retinoblastoma Protein Defective Cancer: Analysis of the Retinoblastoma Cell-Killing Effects by Olaparib after Inducing Double-Strand BreaksYuning Jiang, Jason C Yam, Wai Kit Chu
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|April 7, 2025
Does 0.01% atropine have a place as a myopia control therapy?Jason C Yam, Safal Khanal, John R Phillips
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|July 31, 2023
Low-Concentration Atropine Eye Drops for Myopia ProgressionJason C Yam, Jost B Jonas, Dennis S C Lam
Ophthalmology|August 28, 2021
Re: Saxena et al.: Atropine for treatment of childhood myopia in India: multicentric randomized trial (Ophthalmology. 2021;128:1367-1369)Xiu Juan Zhang, Yu Meng Wang, Chi Pui Pang, et al.
The Lancet Regional Health. Western Pacific|August 31, 2023
Digital strategies in the global war on myopiaYih-Chung Tham, Jason C Yam, Ya Xing Wang, et al.
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
The British Journal of Ophthalmology|February 6, 2024
Pan-Indian multicentre retrospective study of 0.01% atropine for myopia controlJason C Yam, Yuzhou Zhang
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|September 4, 2019
Low-Concentration Atropine Eye Drops for Myopia ProgressionFen Fen Li, Jason C Yam
BMC Ophthalmology|June 6, 2022
A retrospective study of strabismus surgery in a tertiary eye hospital in the Chaoshan area in China from 2014 to 2020Yu Bi, Jason C Yam, Shibin Lin
American Journal of Ophthalmology|June 6, 2022
Reply to Comment on: The Association of Choroidal Thickening by Atropine with Treatment Effects for Myopia: Two-Year Clinical Trial of the LAMP StudyXiu Juan Zhang, Yuzhou Zhang, Jason C Yam
JAMA|June 6, 2023
Low-Concentration Atropine Eyedrops for Myopia in Children-ReplyXiu Juan Zhang, Yuzhou Zhang, Jason C Yam
International Journal of Molecular Sciences|October 13, 2021
Poly ADP Ribose Polymerase Inhibitor Olaparib Targeting Microhomology End Joining in Retinoblastoma Protein Defective Cancer: Analysis of the Retinoblastoma Cell-Killing Effects by Olaparib after Inducing Double-Strand BreaksYuning Jiang, Jason C Yam, Wai Kit Chu
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|April 7, 2025
Does 0.01% atropine have a place as a myopia control therapy?Jason C Yam, Safal Khanal, John R Phillips
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|July 31, 2023
Low-Concentration Atropine Eye Drops for Myopia ProgressionJason C Yam, Jost B Jonas, Dennis S C Lam
Ophthalmology|August 28, 2021
Re: Saxena et al.: Atropine for treatment of childhood myopia in India: multicentric randomized trial (Ophthalmology. 2021;128:1367-1369)Xiu Juan Zhang, Yu Meng Wang, Chi Pui Pang, et al.
The Lancet Regional Health. Western Pacific|August 31, 2023
Digital strategies in the global war on myopiaYih-Chung Tham, Jason C Yam, Ya Xing Wang, et al.
Pageof 18